Review Article
Innovation in Oncology Drug Development
Table 2
Median yearly cost in the US of 51 new oncology drugs approved between 2009 and 2014 [3].
| |||||||||||||||||||
ORR: objective response rate. PFS: progression fee survival. OS: overall survival (table adapted from [3]). |